
Towa US
Breckenridge Pharmaceutical
US
Founded in 1983, Breckenridge Pharmaceutical manufactures, markets and distributes generic medicines in the United States.
We act as a private label distributor with our own and third-party products, offering our development and manufacturing partners a unique opportunity to reach out to US society. Since 2007, Breckenridge has expanded to authorize generic (GA), ANDA and Paragraph IV drugs. Breckenridge has an experienced team. We market approximately 70 products in a variety of dosage forms including: tablets, capsules, softgels, liquids, suspensions, ophthalmics, nasal sprays and powders. We manage
more than 40 CMOs for product sourcing.
We have strong agreements with the three major distribution groups to access all major sales channels: retail chains, independents, mail order, hospitals, long-term care, HMO/Clinical, speciality and government markets.
Fueling Our Growth.
Embracing the power of partnership, we seek strategic acquisitions, licensing agreements, and co-development ventures. Our commitment to forging strong alliances enables us to elevate our core commitment to improving people’s health.
Our presence






